Paul A. Hanly

Dr. Paul A. Hanly


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2020 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
Christopher J. LongoChristopher J. Longo
Christopher J. Longo
MFMargaret I Fitch
Margaret I Fitch
LBLaura Banfield
Laura Banfield
PHPaul A. Hanly
Paul A. Hanly
KYK. Robin Yabroff
K. Robin Yabroff
LSLinda Sharp
Linda Sharp

26 March 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
PHPaul A. Hanly
Paul A. Hanly
LSLinda Sharp
Linda Sharp
Most measures of the cancer burden take a public health perspective. Cancer also has a significant economic impact on society. To assess this economic burden, we estimated years of potential productive life lost (YPPLL) and costs of lost productivity due to premature cancer-related mortality in Ireland.


7 May 2013 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
PHPaul A. Hanly
Paul A. Hanly
ACAlan Ó Céilleachair
Alan Ó Céilleachair
MSMairead Skally
Mairead Skally
EOEamonn O’lEary
Eamonn O’lEary
KKKanika Kapur
Kanika Kapur
LSLinda Sharp
Linda Sharp
Cancer treatment is increasingly delivered in an outpatient setting. This may entail a considerable economic burden for family members and friends who support patients/survivors. We estimated financial and time costs associated with informal care for colorectal cancer.

27 September 2021 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
MOMarta Ortega‐Ortega
Marta Ortega‐Ortega
PHPaul A. Hanly
Paul A. Hanly
APAlison Pearce
Alison Pearce
ISIsabelle Soerjomataram
Isabelle Soerjomataram
LSLinda Sharp
Linda Sharp

4 April 2014 in Expert Review of Pharmacoeconomics & Outcomes Research
Verified
Journal Article
Closed access
PHPaul A. Hanly
Paul A. Hanly
APAlison Pearce
Alison Pearce
LSLinda Sharp
Linda Sharp
(2014). The cost of premature cancer-related mortality: a review and assessment of the evidence. Expert Review of Pharmacoeconomics & Outcomes Research: Vol. 14, No. 3, pp. 355-377.